Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:AMTM
NYSE:AMTMProfessional Services

Amentum Holdings (AMTM) Profitability Turn Reinforces Bullish Narratives Despite High P E Ratio

Amentum Holdings (AMTM) opened Q1 2026 with revenue of about US$3.2b and net income of US$44m, translating to basic EPS of US$0.18, as the market weighs these numbers against a share price around US$32.06. Over recent quarters, the company has seen revenue move from US$3.4b in Q1 2025 to US$3.9b in Q4 2025 and then to US$3.2b in Q1 2026, while basic EPS shifted from US$0.05 to US$0.16 over the same 2025 span before landing at US$0.18 this quarter. This sets up a story where profitability...
TSX:ENB
TSX:ENBOil and Gas

Is It Too Late To Consider Enbridge (TSX:ENB) After Strong Multi Year Share Price Gains

If you are wondering whether Enbridge shares still offer value at today's price, this article walks through the key numbers so you can judge the stock with more confidence. With the share price at C$69.25 and returns of 2.9% over 7 days, 9.0% over 30 days, 4.8% year to date, 13.5% over 1 year, 56.6% over 3 years and 114.2% over 5 years, many investors are asking what that means for value today. Recent attention on Enbridge has centred on how its share price performance fits into a longer...
NYSE:RIG
NYSE:RIGEnergy Services

Transocean Valaris Merger Reshapes Offshore Drilling And Investor Thesis

Transocean (NYSE:RIG) has agreed to acquire Valaris in an all stock merger, creating what management describes as the world’s largest offshore drilling company. The deal brings together two major offshore drillers and combines their rig fleets, geographic reach, and customer bases. The companies highlight expected cost synergies and a larger, more diversified contract portfolio as key benefits of the transaction. For you as an investor, this move comes with NYSE:RIG trading at $5.44, after...
ENXTPA:GET
ENXTPA:GETInfrastructure

Is It Too Late To Consider Getlink (ENXTPA:GET) After Strong Multi Year Share Gains?

If you are looking at Getlink and wondering whether €17.20 per share is a fair price or an opportunity, you are in the right place for a closer look at what that means for value. Over shorter periods the stock has posted returns of 2.2% over 7 days, 4.6% over 30 days, 8.1% year to date, 12.5% over 1 year, 14.5% over 3 years and 43.3% over 5 years. This naturally raises questions about how much of the story is already reflected in the current price. Recent news flow around Getlink has focused...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Is Zebra Technologies (ZBRA) Offering Opportunity After Recent Share Price Volatility?

If you are wondering whether Zebra Technologies at around US$256.57 is a bargain or a value trap, you are not alone, as the share price and the fundamentals are sending some very mixed signals. Over the past week the stock is up 10%, yet the 30 day return is a 1.1% decline and the longer term record shows returns of 3.3% year to date, a 27.6% decline over 1 year and a 47.2% decline over 5 years. Recent coverage has focused on how investors are reassessing hardware focused tech names like...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Krystal Biotech RMAT Win For KB707 And What It Means For Valuation

Krystal Biotech received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for KB707, an inhaled, redosable immunotherapy for advanced non small cell lung cancer. The designation is based on early clinical evidence that KB707 may provide meaningful antitumor activity in advanced or metastatic NSCLC. RMAT status can create a faster and more flexible regulatory path for therapies targeting serious or life threatening conditions. For Krystal Biotech, ticker NasdaqGS:KRYS, this...
TSX:SLF
TSX:SLFInsurance

Is Sun Life Financial (TSX:SLF) Pricing In Its Long Term Growth After Recent Flat Trading?

If you are wondering whether Sun Life Financial's current share price fairly reflects its long term potential, you are not alone. That is exactly what this article will unpack. The stock last closed at C$87.44, with returns of 9.3% over 1 year, 46.2% over 3 years, and 74.4% over 5 years, which may have changed how investors view its risk and reward profile. Recent headlines around large insurers have focused on topics such as capital strength, regulatory developments, and demand for wealth...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio Advances Chemotherapy Free Immunotherapies And Faces Key Investor Tests

ImmunityBio (NasdaqGS:IBRX) is participating in the 2026 ASCO Genitourinary Cancers Symposium, highlighting its work in cancer immunotherapies. The company recently expanded use of its therapy Anktiva for lung cancer patients in Saudi Arabia following regulatory approval. ImmunityBio launched the ResQ215B Phase 2 trial, studying a chemotherapy free regimen for B cell non Hodgkin lymphoma. ImmunityBio focuses on developing cancer immunotherapies that aim to work with the immune system rather...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

Copart Credit Facility Expands Flexibility For Growth And Shareholder Returns

Copart has secured a new $1.25b unsecured senior revolving credit facility. The facility is intended to support acquisitions, capital spending, share repurchases, and international expansion. This new credit line provides additional financial flexibility alongside Copart’s existing resources. For investors watching Copart (NasdaqGS:CPRT), the new facility arrives with the stock trading at $40.35. Over the past week, the share price return is 3.6%, with a 6.8% return year to date and a 16.5%...
NYSE:ACRE
NYSE:ACREMortgage REITs

Ares Commercial Real Estate Q4 Revenue Slump Reinforces Bearish Credit Risk Narratives

Ares Commercial Real Estate FY 2025 Earnings Snapshot Ares Commercial Real Estate (ACRE) has wrapped up FY 2025 with a mixed top line, reporting Q4 total revenue of US$3.4 million alongside basic EPS of a US$0.07 loss per share. The trailing twelve months show total revenue of US$72.7 million and basic EPS of roughly flat at a US$0.02 loss. Across recent quarters, the company has seen revenue move from US$18.5 million in Q4 2024 to US$20.3 million in Q1 2025, US$32.7 million in Q2 2025,...
TSE:5715
TSE:5715Machinery

Furukawa Ltd (TSE:5715) One Off Gain Clouds EPS Narratives After Q3 2026 Results

Furukawa Ltd (TSE:5715) has put up a punchy Q3 2026 print, with revenue of ¥52,339 million and basic EPS of ¥145.02, set against a trailing 12 month revenue base of ¥204,991 million and EPS of ¥429.40. Over recent quarters the company has seen revenue move from ¥45,865 million in Q2 2025 to ¥55,017 million in Q4 2025, then settle at ¥52,339 million in Q3 2026. Quarterly EPS has ranged from ¥176.83 in Q2 2025 to ¥70.21 in Q1 2026 before landing at ¥145.02 this quarter. With net income trends...
NYSE:SYF
NYSE:SYFConsumer Finance

Does Synchrony (SYF) Monthly Credit Updates Deepen Investor Trust in Its Risk Profile Story?

Earlier this month, Synchrony Financial reported its latest monthly charge-off and delinquency statistics for the thirteen months to January 31, 2026, while also participating in the UBS Financial Services Conference 2026 in Key Biscayne, Florida. This continued transparency on core credit metrics gives investors a clearer view of Synchrony’s credit quality trends and portfolio health between quarterly results. Next, we’ll explore how this enhanced visibility into monthly credit performance...
NYSE:KNTK
NYSE:KNTKOil and Gas

How Kinetik’s Dividend Hike and ECCC Progress Could Shape Kinetik Holdings (KNTK) Investors

Kinetik Holdings recently raised its quarterly dividend by 4% and highlighted progress on its ECCC pipeline project in the Permian Basin, underscoring management’s focus on shareholder payouts and infrastructure growth. This combination of a higher cash return and an advancing pipeline project adds a fresh income-and-projects angle to the company’s midstream story. Next, we’ll examine how the dividend increase reshapes Kinetik’s existing investment narrative around growth projects and...
NYSE:ABBV
NYSE:ABBVBiotechs

Assessing AbbVie (ABBV) Valuation After Strong Q4 Results And New Rinvoq Filings

Why AbbVie’s latest earnings and pipeline moves matter now AbbVie (ABBV) has just paired a strong fourth quarter with two important developments: a credit rating upgrade and fresh regulatory filings for Rinvoq in non segmental vitiligo, giving investors several new data points to assess. See our latest analysis for AbbVie. Despite the recent credit upgrade and Rinvoq filings, AbbVie’s 1 month share price return of 1.07% and year to date decline of 3.00% suggest near term momentum is still...
NasdaqGS:CFLT
NasdaqGS:CFLTSoftware

What Confluent (CFLT)'s Slower Growth Outlook This Earnings Season Means For Shareholders

Confluent (NASDAQ:CFLT) is set to report its latest quarterly earnings after market close this Wednesday, with analysts expecting revenue of US$307.9 million, implying year-on-year growth that is slower than the same period last year. The company recently exceeded revenue expectations and expanded its base of large enterprise customers, so investors are watching closely to see whether this momentum can offset concerns about moderating growth. Next, we’ll examine how expectations for slowing...
NYSE:BLK
NYSE:BLKCapital Markets

How Investors May Respond To BlackRock (BLK) ETF Expansion, Crypto Volatility Flows, And ESG Court Win

In recent days, BlackRock has seen heightened attention as its iShares ETFs prepare for an asset infusion, its spot bitcoin ETF logged record trading volumes during a crypto selloff, and a Texas court ruling struck down a state anti-ESG law affecting the firm’s ability to use sustainability factors in investing. Together, these developments spotlight how BlackRock’s breadth across ETFs, digital assets, and ESG-related mandates can influence how investors think about its long-term product...
NasdaqGS:WB
NasdaqGS:WBInteractive Media and Services

Is Weibo’s Renewed Gala Partnership Deepening Its User Engagement and Monetization Story (WB)?

On 10 February 2026, CCTV announced Weibo as the official copyright video partner for the 2026 Spring Festival Gala, marking their twelfth consecutive year of collaboration and reinforcing Weibo’s role in the event’s digital experience. This renewed partnership highlights how Weibo’s deep integration into a flagship national broadcast can reinforce user engagement and advertiser interest on its platform. We’ll now examine how Weibo’s renewed Spring Festival Gala role might influence its...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

How LKQ's Portfolio Shake-Up and Cost Cuts Will Impact LKQ (LKQ) Investors

LKQ Corporation has recently intensified its portfolio review, selling non-core Self Service and Specialty operations and targeting an additional US$75.00 million in annual cost savings to reshape its business mix. This combination of asset disposals and tighter cost controls highlights management’s attempt to address weak cash flow progress and concerns about returns on recent investments. We’ll now explore how these asset sales and cost-cutting plans may influence LKQ’s existing investment...
NYSE:SQM
NYSE:SQMChemicals

SQM Expands Lithium Capacity As Shares Trade Below Estimated Fair Value

Sociedad Química y Minera de Chile (NYSE:SQM) is ramping up lithium production capacity to meet strong demand. The company is moving ahead with expansion projects even as the broader lithium sector faces headwinds. Management is also prioritizing growth in specialty plant nutrition alongside its lithium business. Sociedad Química y Minera de Chile, or SQM, is a Chile based specialty chemicals producer with a major focus on lithium and specialty plant nutrition. While parts of the lithium...